FDA denies request for expedited approval of Alzheimer’s drug
By
John Roszkowski
Jan 23, 2023
The Food and Drug Administration late last week denied Ely Lilly’s request for expedited approval of the Alzheimer’s drug donanemab, citing the need for more clinical trials to test the safety and...